+33,932.9%
MCHP vs GSK
+1,040.2%
+32,892.7%
-63.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -2.3% | +3.7% | +2.2% |
| 7D | -1.5% | -3.0% | +1.5% | -0.4% |
| 30D | -19.5% | +0.4% | -19.9% | -19.8% |
| 3M | -25.5% | -1.2% | -24.3% | -25.6% |
| 6M | -36.0% | +0.9% | -36.9% | -37.1% |
| YTD | -5.1% | +4.0% | -9.1% | -8.4% |
| 1Y | +18.0% | +7.3% | +10.7% | +12.6% |
| 3Y | -23.3% | +57.1% | -80.3% | -38.4% |
| 5Y | -20.0% | +43.0% | -63.0% | -34.5% |
| 10Y | +118.2% | +103.1% | +15.1% | +56.4% |
| All | +33,932.9% | +1,040.2% | +32,892.7% | +16,637.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling